Anumana, a leading company in AI-driven health technology, has announced that the Centers for Medicare & Medicaid Services (CMS) has included its low ejection fraction

Fusion Orthopedics, LLC has won a significant victory following a decision by the United States Patent and Trademark Office's (USPTO) Patent Trial and Appeal Board (PTAB). The PTAB ruled that 14 claims

SimBioSys?, an innovative TechBio company specialising in spatial biophysics and artificial intelligence (AI), has launched its second clinical application, TumorSight Plan. This application aims to transform surgical planning

Versiti Blood Center of Ohio has announced the acquisition of Solvita Blood Center, formerly known as Community Blood Center. This strategic move aims to strengthen Versiti's presence

Liver disease affects an estimated 1.5 billion people globally, with many cases undiagnosed until late stages. As liver conditions like metabolic dysfunction-associated steatotic liver disease

C2N Diagnostics, LLC, a leading developer of Alzheimer?s disease-specific fluid biomarker tests, has secured a new investment of $15 million from the GHR Foundation to advance the development of tests focused on tau tangle pathology

Nightingale Health Plc?s US subsidiary, Nightingale Health United States Inc., has partnered with Boston Heart Diagnostics Corporation following a successful pilot programme launched in June

Imbed Biosciences has received FDA 510(k) clearance to market Microlyte? Ag/Lidocaine, a groundbreaking antimicrobial wound dressing that incorporates lidocaine for the treatment of painful skin wounds

Paragonix Technologies, a leader in organ transplant technologies and procurement services, has achieved a significant milestone by successfully completing the first-ever human case using its innovative PancreasPak?

Telix Pharmaceuticals has partnered with California-based Subtle Medical, Inc. to integrate artificial intelligence (AI) into positron emission tomography (PET) imaging for its Illuccix?